Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous calcium gluconate for reducing intraoperative blood loss during caesarean section
PACTR202601807808004Not yet recruiting
- Sponsor
- Confidence Ogbomade
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of calcium gluconate in postpartum hemorrhage (PPH) (2 arms), sponsored by Confidence Ogbomade. Primary endpoint: Mean intraoperative blood loss during caesarean section. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
calcium gluconate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202601807808004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601807808004.